View Single Post
Old 09-23-2007, 06:20 PM
HeyJoe HeyJoe is offline
Member
 
Join Date: Sep 2006
Location: New York
Posts: 461
15 yr Member
HeyJoe HeyJoe is offline
Member
 
Join Date: Sep 2006
Location: New York
Posts: 461
15 yr Member
Default

http://www.cytokineinstitute.com/pdfs/chromium.pdf




This is from the cytokine institute also, not too hard after reading this to see where they envision it going, and its not concern for health of the person.

AccuHealth Monitoring™ Type II

Providing a basic and accurate understanding of insurance applicants, the AccuHealth Monitoring™ Type II protocol affords the determination of the overall health and well-being of that individual in comparison to known standards of normalcy. Because it provides a more complete health picture than Type I monitoring, it offers an opportunity to inform applicants of possible occult disease processes which could have acute, chronic, and/or future adverse health consequences.

AccuHealth Monitoring™ Type II is a 15-part cytokine/chemokine protocol that provides objective evidence for identifying numerous risk factors for maladies, including, but not limited to, cardiovascular disease, oncologic illnesses, spinal cord injuries, central nervous system disorders, ongoing traumatic processes, joint-related disease, fibromyalgia, autoimmune ailments, pulmonary maladies ranging from asthma to emphysema, diabetes, and cerebrovascular disease. Whether a health questionnaire was completed accurately or a pre-insurance physical examination was done thoroughly, the ability to detect and monitor numerous acute and chronic maladies can uncover and delineate a far more insightful medical picture of an about-to-be insured. By uncovering this information, individuals can be counseled to seek appropriate medical intervention and institute any necessary preventive or therapeutic medical care.
HeyJoe is offline   Reply With QuoteReply With Quote